\renewcommand\labelitemii{$\vcenter{\hbox{\tiny$\bullet$}}$} - 任何代码示例 📅 最后修改于: 2022-03-11 14:55:45.956000 🧑 作者: Mangohttps:fontawesome.com 表格 - 任何代码示例 georgenotfound - 任何代码示例 代码示例1 \renewcommand{\labelitemi}{\raise .5ex\hbox{\tiny$\bullet$}} ...
From April 2011 to March 2018, a total of 122 patients underwent transcatheter closure by ADO II and 66 patients by ADO II AS. The number of PDA closure with ADO II was 48; with ADO II AS were 62. Rest of the procedures were all off-label. Types of off-labe...
A phase II, open‐label, multicenter study of capivasertib, a potent, oral pan‐AKT inhibitor, in patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma (CAPITAL)doi:10.1002/hon.3164_421NON-Hodgkin's lymphomaMANTLE cell lymphoma...
Multicenter Randomized Open-Label Phase II Clinical Study Comparing Outcomes of NK105 and Paclitaxel in Advanced or Recurrent Breast Cancerdoi:10.2147/IJN.S372477Yoshimasa KosakaToshiaki SaekiToshimi TakanoTomoyuki ArugaToshinari YamashitaNorikazu Masuda...
A multicenter, open‐label, phase II trial of pemetrexed plus bevacizumab in elderly patients with previously untreated advanced or recurrent nonsquamous non‐small cell lung cancerdoi:10.1111/1759-7714.15115Yabuki, YoheiHanibuchi, MasakiTakeuchi, Eiji...
Long Term Follow-Up Study of a Randomized, Open-Label, Uncontrolled, Phase I/II Study to Assess the Safety and Immunogenicity of Intramuscular and Intradermal Doses of COVID-19 DNA Vaccine (AG0302-COVID19)doi:10.3390/vaccines11101535DNA vaccines...
A phase II open-label randomized trial of tretinoin in patients with Chronic Rhinosinusitis with Nasal PolypsAntonio, Marcelo A.Marson, Fernando A. L.Sampaio, Marcelo H.Toro, Mariana D. C.Barreto, Icleia S.Dertkigil, Sérgio S. J.
DT‐02‐03: OPEN LABEL EXTENSION RESULTS FROM A PHASE II/III TRIAL OF INTRANASAL INSULINdoi:10.1016/j.jalz.2019.08.012Craft, SuzanneRaman, RemaChow, Tiffany W.Rafii, Michael S.Rissman, Robert A.Brewer, James B.Donohue, Michael C.
Phase II open‐label multicenter study to assess the antitumor activity of afatinib in lung cancer patients with activating epidermal growth factor receptor mutation from circulating tumor DNA: Liquid‐Lung‐Adoi:10.1111/1759-7714.13763Park, Cheol‐Kyu...
A label-free lead(II) ion sensor based on surface plasmon resonance and DNAzyme-gold nanoparticle conjugatesSURFACE plasmon resonanceLEADGOLD nanoparticlesHEAVY metalsDETECTORSDEOXYRIBOZYMESLEAD removal (Water purification)Detection of lead(II) (Pb2 ) ions in water is important...